Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia

Yoshihiro Noji(Fukui Prefectural Hospital), Hiroshi Mabuchi(Kanazawa University), Susumu Miyamoto(Kyoto University Hospital), Atsushi Nohara(Kanazawa University), Tadayoshi Takegoshi(Uwajima City Hospital), Junji Koizumi(Kanazawa University), Toshinori Higashikata(Kanazawa University), Akihiro Inazu(Kanazawa University), Kouji Kajinami, Kosei Ueda(Ueda Womens Junior College)
Atherosclerosis
July 1, 2002
10.1016/s0021-9150(01)00765-1
Cited by 74

Related Papers

Increased High-Density Lipoprotein Levels Caused by a Common Cholesteryl-Ester Transfer Protein Gene Mutation
|New England Journal of Medicine|1990|865
Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins
|Nature|1989|465
T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity
|Clinical Science|2003|313
T‐peak to T‐end interval may be a better predictor of high‐risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin i mutation than qt dispersion
|Clinical Cardiology|2002|267
Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.
|Circulation|1981|250